As of January 17, 67 GEM companies announced their 2023 performance forecasts. According to statistics according to the type of performance forecast, there were 41 pre-profit companies and 8 pre-profit companies. The total proportion of good news companies was 73.13%; there were 14 companies with pre-decline in performance and 1 loss reduction company, respectively. Among the companies that are expected to perform well, according to the median estimated net profit increase, a total of 20 companies increased their net profit by more than 100%; 12 had net profit increases between 50% and 100%. Specifically, Puri Ophthalmology expects the highest increase in net profit. The company expects to achieve a median net profit increase of 1224.75% in 2023; Kangtai Biotech and Jubilee Technology expect a median year-on-year increase of 778.18% and 625.26% respectively, ranking second and third in terms of increase. (Securities Times)